Loading wiki pages...

Wiki Version:
<p>Background: Persons with opioid use disorder (OUD) who are incarcerated are highly susceptible to opioid-overdose upon reentry. If initiated prior to release, extended-release naltrexone (XR-NTX) provides ~30 days of opioid-overdose protection in the community. XR-NTX's high cost is perceived as a barrier.</p> <p>Objectives: Estimate implementation and ongoing-management costs associated with different strategies of XR-NTX delivery to persons with OUD upon reentry.</p> <p>Methods: Data were from two multisite randomized-controlled effectiveness trials comparing pre-release XR-NTX + referral to community pharmacotherapy to: referral only (Study A); pre-release XR-NTX + post-release place-of-residence/mobile treatment (Study B). A micro-costing approach was used. We solicited estimates of resources required to deliver each strategy. All intervention-relevant resources were included and valued. The resource-costing method was used, with unit costs derived from sources reflecting national "real-world" costs. Resources varied by study, and included: labor, medication, supplies, and provider travel (mileage, time). Costs were categorized as fixed, time-dependent, and variable. Year 1 costs included (a), (b), and (c) variable. Subsequent annual costs included (b) and (c).</p> <p>Results: The in-prison XR-NTX process was estimated to take 2-3.5 hours. Study A adopted an in-house model. Study B's intervention was delivered by an outside team. Fixed/one-time costs and time-dependent costs were minimal; consequently, per-patient costs vary little with changes in patient caseload. Assuming full capacity, Year 1, per-patient costs were estimated as 979 dollars (Study A), and 3,458 dollars (Study B); subsequent annual costs were 976 dollars/patient and 3,453 dollars/patient, respectively. 1,320 dollars/patient in Study B was associated with travel to prison, and 1,007 dollars/patient was associated with the post-release mobile portion.</p> <p>Conclusions: Results are valuable to stakeholders interested in expanding XR-NTX OUD treatment in justice settings.</p>
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.